Once-daily budesonide inhalation suspension in infants and children <4 and ≥4 years of age with persistent asthma

Annals of Allergy, Asthma and Immunology

Volumn 87, Issue 6, 2001, Pages 488-495

  Scott, Maryanne B ^a   Ellis, Mark H ^b   Cruz Rivera, Mario ^c   Fitzpatrick, Sherahe ^c   Smith, Joseph A ^c  

^a Fairfield County Allergy Asthma and Immunology Associates   (United States)

^b CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^c ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CORTICOSTEROID;

ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; OTITIS MEDIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; RHINITIS; SCHOOL CHILD; SINUSITIS;

EID: 0035665373     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62262-4     Document Type: Article

References (39)

1. Asthma mortality and hospitalization among children and young adults - United States, 1980-1993
2. Surveillance for asthma - United States, 1960-1995
3. Changes in asthma prevalence: Two surveys 15 years apart
4. Asthma - United States, 1982-1992
5. Morbidity and mortality of asthma
6. The increasing problem of asthma in the United States
7. Inflammation in asthma: The cornerstone of the disease and target of therapy
8. Mucosal inflammation in asthma
9. Asthma
10. Airways remodelling in asthma: No doubt, no more?
11. Asthma and anaphylaxis: A relevant model for chronic disease? An historical analysis of directions in asthma research
12. Molecular mechanisms of glucocorticoid action in asthma
13. Management of asthma
14. Efficacy of inhaled corticosteroids in asthma
15. Effects of inhaled corticosteroids on the consequences of asthma
16. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children
17. Effects of reducing or discontinuing budesonide in patients with mild asthma
18. Airway remodelling takes place in asthma - What are the clinical implications?
19. Effect of early vs late intervention with inhaled corticosteroids in asthma
20. Aggressive treatment of childhood asthma with local steroids. Good or bad?
21. Use of budesonide in severe asthmatics aged 1-3 years
22. Efficacy of nebulized budesonide in treatment of severe infantile asthma: A double-blind study
23. Nebulised budesonide in severe infantile asthma
24. Treatment of severe steroid dependent preschool asthma with nebulised budesonide suspension
25. Rapid induction of clinical response with a short-term high-dose starting schedule of budesonide nebulizing suspension in young children with recurrent wheezing episodes
26. Nebulized budesonide for the treatment of moderate to severe asthma in infants and toddlers
27. A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for the treatment of persistent asthma in young children and infants
28. Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children
29. Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma
30. Budesonide inhalation suspension (BIS; Pulmicort Respules) twice-daily in children <4 and ≥4 of age with persistent asthma
31. Long term study of nebulized budesonide in young children with moderate to severe asthma
32. Comparative study of budesonide as a nebulized suspension vs pressurized metered-dose inhaler in adult asthmatics
33. Budesonide suspension for nebulization in children with asthma
34. Dose titration of nebulized budesonide in young children
35. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma
36. Comparable efficacy of administration with face mask or mouthpiece of nebulized budesonide inhalation suspension for infants and young children with persistent asthma